Advertisement
Canada markets close in 2 hours 15 minutes

  • S&P/TSX

    21,684.58
    -55.62 (-0.26%)
     

  • S&P 500

    5,059.68
    -2.14 (-0.04%)
     

  • DOW

    37,859.62
    +124.51 (+0.33%)
     

  • CAD/USD

    0.7236
    -0.0017 (-0.23%)
     

  • CRUDE OIL

    85.21
    -0.20 (-0.23%)
     

  • Bitcoin CAD

    86,933.79
    -1,287.73 (-1.46%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • GOLD FUTURES

    2,403.60
    +20.60 (+0.86%)
     

  • RUSSELL 2000

    1,968.07
    -7.64 (-0.39%)
     

  • 10-Yr Bond

    4.6820
    +0.0540 (+1.17%)
     

  • NASDAQ

    15,890.30
    +5.28 (+0.03%)
     

  • VOLATILITY

    18.54
    -0.69 (-3.61%)
     

  • FTSE

    7,820.36
    -145.17 (-1.82%)
     

  • NIKKEI 225

    38,471.20
    -761.60 (-1.94%)
     

  • CAD/EUR

    0.6810
    -0.0014 (-0.21%)
     
MARKETS LIVE BLOG:

STOCKS TRADE MIXED AS COMPANY EARNINGS ROLL IN

Shares of Live Nation, parent company of Ticketmaster, fall on antitrust probe report

AXAS, POZN, ATRS and BGMD added to NASDAQ Active Stock Watch List at EPR

ACCESSWIRE

New York, NY - (ACCESSWIRE) - 11/06/2013 - Equity Profile Report initiates its NASDAQ Active Stock Watch List adding Abraxas Petroleum Corp. (NASDAQ:AXAS - News), POZEN Inc. (NASDAQ:POZN - News), Antares Pharma Inc. (NASDAQ:ATRS - News), and BG Medicine, Inc. (NASDAQ:BGMD - News)

Abraxas Petroleum Corp. (NASDAQ:AXAS - News) an independent energy company that engages in the acquisition, exploitation, development, and production of oil and gas in the United States and Canada closed down in its previous session (-0.66%) on 1,218,767 shares traded. Abraxas Petroleum Corp. (NASDAQ:AXAS - News) is currently down (-5.96%) from its recent 52-week high, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.

To find out what other Investors are saying about Abraxas Petroleum Corp. (NASDAQ:AXAS - News)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=AXAS&SubId=AW

ADVERTISEMENT

POZEN Inc. (NASDAQ:POZN - News) a pharmaceutical company that develops products for the treatment of acute and chronic pain, and pain related conditions in the United States closed down in its previous session (-0.46%) on 269,515 shares traded. POZEN Inc. (NASDAQ:POZN - News) is currently down (-2.12%) from its recent 52-week high, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.

To find out what other Investors are saying about POZEN Inc. (NASDAQ:POZN - News)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=POZN&SubId=AW

Antares Pharma Inc. (NASDAQ:ATRS - News) operates as a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies, and topical gel-based medicines worldwide closed down in its previous session (-1.52%) on 1,323,012 shares traded after Antares Pharma Appointed Dr. Bruce Freundlich as Senior Vice President. Antares Pharma Inc. (NASDAQ:ATRS - News) is currently down (-24.47%) from its recent 52-week high, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.

To find out what other Investors are saying about Antares Pharma Inc. (NASDAQ:ATRS - News)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=ATRS&SubId=AW

BG Medicine, Inc. (NASDAQ:BGMD - News) a diagnostics company that engages in the development and commercialization of novel cardiovascular diagnostic tests to address unmet medical needs in the United States closed down in its previous session (-1.11%) on 178,534 shares traded after BG Medicine, Inc. today announced that will host a conference call and webcast on Wednesday, November 6 at 8:30 a.m. Eastern Time to discuss its third quarter 2013 financial results. BG Medicine, Inc. (NASDAQ:BGMD - News) is currently down (-86.38%) from its recent 52-week high, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.

To find out what other Investors are saying about BG Medicine, Inc. (NASDAQ:BGMD - News)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=BGMD&SubId=AW

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure: Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com